View all news

Bristol spin-out Dynamic Therapeutics wins prestigious Blavatnik Prize for U-RHYTHM technology

Press release issued: 25 April 2024

Dynamic Therapeutics, a University of Bristol spin-out, has today [25 April] been awarded a prestigious Blavatnik Prize by QantX, a leading venture capital firm, for its pioneering U-RHYTHM technology. The award recognises the scientific advances and future potential of the UK's most innovative scientists and engineers.

Hormones play a crucial role in many aspects of our health from regulation of metabolism to growth and development, and reproduction to stress responses, managing mood, emotions and sleep-wake cycles. Monitoring them is difficult as not only do hormone levels vary greatly across the day but also by individual patient. Standard techniques for the diagnosis and management of hormone-related disorders rely on taking single measurements usually in the morning, which is problematic because many hormone levels change in an oscillating manner. 

In contrast, U-RHYTHM measures the patterns of biologically active molecules in the tissues and how they change over time. This information can be analysed to identify potential - and importantly the early - disruptions which could affect a patient's health. 

Dynamic Therapeutics was founded by Professor Stafford LightmanDr Georgina Hazell from Bristol Medical School and Alex Caccia, and is based on more than 25 years research on hormones. 

Read the full University of Bristol news item

Edit this page